May 29, 2024 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the heart muscle. As it progresses, the heart can become unable to adequately …

A big problem in ATTR-CM is the buildup of amyloid proteins in the heart. New treatments aim to remove these proteins, which could help your heart work better and ease symptoms.

Mar 2, 2022 · Transthyretin cardiac amyloidosis (or ATTR-CM for short) is a heart condition that can lead to heart failure, and it can be fatal. Unfortunately, many of its symptoms are vague, which may …

Transthyretin amyloidosis (ATTR-CM) is a buildup of faulty proteins (fibrils) on your heart or nerves. It can cause cardiomyopathy and heart failure.

Apr 8, 2025 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of heart disease that happens when an abnormal protein called amyloid builds up in the heart. Because the symptoms can look …

Jun 26, 2025 · ATTR-CM (transthyretin amyloid cardiomyopathy) is a rare condition that causes a range of vague symptoms, including shortness of breath. If left untreated, it can progress to heart failure.

Explore the red flags of transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM), the signs and symptoms that should prompt additional assessments.

Jul 10, 2025 · What is ATTR-CM? Read on to learn more about this rare type of heart disease, including possible causes, different forms, symptoms, and treatments.

This syndrome is an extracardiac manifestation of ATTR cardiac amyloidosis and may precede clinical heart failure symptoms by several years —as many as 5 to 7 years in ~50% of patients with wtATTR …

Mar 3, 2025 · The Good Brigade/Getty Images Transthyretin amyloid cardiomyopathy, or ATTR-CM, is an underdiagnosed heart condition with symptoms that mimic other conditions. Here’s how to …